Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
Researchers at the University of Florida have discovered the combination of Lactoferrin, a protein found in cow and human milk, and diphenhydramine, an antihistamine used for allergy symptoms, increased resilience of mice towards the virus that causes COVID-19.
Combination of Two Common Compounds Improves COVID Survival in Mice, UF Researchers Find
UF researchers have discovered a combination of two over-the-counter compounds that may significantly improve the recovery of patients infected with COVID-19. Studies in mice have been successful, with the health of test subjects improving significantly or ending in full recovery.
Can Milk Cure COVID-19? Not Exactly, but a New Treatment Shows Promise
College of Medicine researcher Dr. David Ostrov wrote this opinion piece for The Hill after his discovery of a potential therapy or preventative for COVID became public knowledge:
“Got milk? Cure COVID” was a meme that started circulating after one of our discoveries from the University of Florida went public. It playfully highlighted a major medical milestone: We had found a combination of two over-the-counter products that could inhibit 99 percent of SARS-CoV-2 replication in human lung cells, and one of them was milk-based.
Neobiosis Announces FDA Approval of IND for Use of ViXomeTM in COVID-19 ‘Post COVID Syndrome’
Neobiosis, A UF Accelerate resident client, is a leading research and manufacturing biotechnology company focused on pioneering the development of novel therapeutics from perinatal tissues as a new class of medicines. Today, Neobiosis announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for ViXome™, its drug for the treatment of 'Post COVID Syndrome (AKA "Long Haul COVID Syndrome").
AI Helps Create Better, Simpler Hepatitis, COVID-19 Tests
Going beyond pregnancy and COVID-19, the world could someday soon come to rely on at-home tests for many diseases thanks in part to AI-fueled improvements.
UF researchers discover new way to inhibit virus that causes COVID-19
When the virus that causes COVID-19 enters the body, it hijacks cellular proteins and suppresses the human inflammatory response, allowing the virus to spread. University of Florida researchers have discovered a novel way in the lab to fight rapidly evolving strains of coronaviruses by breaking that cycle.
Oragenics Announces Publication of Positive Data for Its Nt-CoV2-1 Intranasal COVID-19 Vaccine Candidate in Scientific Reports
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a biotech company dedicated to fighting infectious diseases including coronavirus, announces the publication of an article co-authored by Oragenics and collaborators at Inspirevax and the National Research Council of Canada (“NRC”) Human Health Therapeutics Research Centre in Scientific Reports, a Nature journal.
UF Study: Post-COVID Mortality Risk May Be Caused by Effects of High Inflammation During Illness
A University of Florida study sheds new light on the reason people who recover from a bout of severe COVID-19 are still at increased risk for death in the year after their recovery. The culprit may be high levels of inflammation during the initial illness.
Using AI in the Arts To Promote COVID-19 Vaccines
Sure, it is fun to see an avatar simulate your body movements in real time, but the interactive augmented reality art installation making its way around campus has a serious aim: educating participants about how COVID-19 impacts health and encouraging vaccination.
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on Its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1
Oragenics, Inc., announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine
